Why Donaco International Ltd (ASX:DNA) shares are sliding today

Asia Pacific leisure and entertainment business Donaco International Ltd (ASX:DNA) has reported an after tax net loss of $124.5 million for FY18.

| More on:
a woman

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Asia Pacific leisure and entertainment business Donaco International Ltd (ASX: DNA) has reported an after tax net loss of $124.5 million for FY18 due to a previously-flagged $143.9 million impairment charge.

Stripping out the impairment – related to the Star Vegas casino license –  the group generated an underlying NPAT of $18.3 million and EBITDA of $42.4 million – as consistent with its April's guidance.

According to Donaco CEO Joey Lim the group is pursuing legal avenues over the Star Vegas casino impairment due to breaches of non-compete clauses.

But Lim says the "balance sheet remains strong" with debt to equity reducing to 6%, but its result revealed a net revenue drop out of Star Vegas and Aristo International.

Entertainment stock big wig Aristocrat Leisure Limited (ASX: ALL) shares are up of late, although the company is not due to report this season, with its preliminary report not due out until November.

Crown Resorts Ltd's (ASX: CWN) share price will be one to watch as the group takes on a NSW Government agency over its new casino at Barangaroo.

Motley Fool contributor Carin Pickworth has no position in any of the stocks mentioned. The Motley Fool Australia owns shares of and has recommended Crown Resorts Limited. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Speculative

Speculative

Bell Potter says this speculative ASX stock can rocket 40%

If you have a high tolerance for risk, then it could be worth checking out Vitrafy Life Sciences Ltd (ASX:…

Read more »

Man pointing an upward line on a bar graph symbolising a rising share price.
Speculative

Why this speculative ASX stock could rise ~50%

Bell Potter sees potential for big returns over the next 12 months.

Read more »

A bearded man holds both arms up diagonally and points with his index fingers to the sky with a thrilled look on his face over these rising Tassal share price
Speculative

These speculative ASX mining stocks could rise 85%+

Bell Potter has put speculative buy ratings on these stocks this morning.

Read more »

surprised asx investor appearing incredulous at hearing asx share price
Speculative

'Blockbuster opportunity': This speculative ASX stock could rise 70%

Bell Potter thinks exciting times could be around the corner for this buy-rated high risk stock.

Read more »

A smiling businessman in the city looks at his phone and punches the air in celebration of good news.
Healthcare Shares

Buy this small cap ASX stock with a 'lucrative opportunity'

Bell Potter thinks this speculative stock could have major upside thanks to its US market opportunity.

Read more »

Man drawing an upward line on a bar graph symbolising a rising share price.
Speculative

Broker says this speculative ASX stock could rise over 200%

This high risk option could have major upside according to analysts.

Read more »

Vanadium Resources share price person riding rocket indicating share price increase
Speculative

Meet the speculative ASX stock tipped to rise 180%

Bell Potter thinks this share could almost triple in value.

Read more »

People sit in rollercoaster seats with expressions of fear, terror and exhilaration as it goes into a steep downward descent representing the Novonix share price in FY22
AI Stocks

Brainchip share price tumbles 40% in the past year. What's next?

Brainchip shares have had a topsy-turvy year. So, what’s next for this speculative ASX AI technology stock?

Read more »